This article presents a question-answer advisory for clinical trial organizers to involve more older people in the research process. Older people, reportedly, comprise almost one in five of the population of most developed countries, yet are systematically excluded from participation in clinical trials. Cardiovascular disease, cancer, and diabetes affect large numbers of older people, hence they are required to be involved in the trial processes. It is suggested that some issues relating to communication like deafness, visual, and cognitive impairment are relatively common in older age groups. These issue must be considered while designing the trial processes. The informed consent process is suggested not to be changed for older people.
|Number of pages||1|
|Journal||Applied Clinical Trials|
|Publication status||Published - Jan 2006|